23andMe claims rights over content you submit to the platform, including any material you provide through the services, and these rights persist even if you stop using the service.
Users who submit content such as survey responses, health information, or other user-generated material to 23andMe grant the company rights to use that content, which may include research or commercial applications beyond what users expected at the time of submission.
Cross-platform context
See how other platforms handle Intellectual Property License Grant and similar clauses.
Compare across platforms →A broad license grant means that content users submit — potentially including health notes, survey responses, and profile information — can be used by 23andMe for commercial or research purposes without additional compensation.
REGULATORY FRAMEWORK: This provision implicates CCPA/CPRA (Cal. Civ. Code §1798.100) regarding secondary use of personal information beyond the disclosed purpose; FTC Act Section 5 applies to deceptive practices if the license scope exceeds reasonable consumer expectations; GINA (29 U.S.C. §2101) is relevant if licensed content includes genetic information used for commercial purposes. Copyright law (17 U.S.C. §101 et seq.) governs the enforceability of the license grant itself.
Compliance intelligence locked
Regulatory citations, enforcement risk, and due diligence action items.
Watcher: regulatory citations. Professional: full compliance memo.